Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher M Harris

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Bioorganic & Medicinal Chemistry Letters|March 30, 2016
Hit-to-lead evaluation of a novel class of sphingosine 1-phosphate lyase inhibitorsJurgen Dinges, Christopher M Harris, Grier A Wallace, et al.
Oecologia|October 17, 2021
Drought at a coastal wetland affects refuelling and migration strategies of shorebirdsAlexandra M Anderson, Christian Friis, Cheri L Gratto-Trevor, et al.
Primer (Leawood, Kan.)|October 4, 2023
Future Doctors From Underrepresented in Medicine Communities at the University of UtahPaloma F Cariello, Edgar Figueroa, Christopher M Harris, et al.
Toxicologic Pathology|June 22, 2016
Syk Inhibition Induces Platelet Dependent Peri-islet Hemorrhage in the Rat PancreasAndrew J Long, Erik Sampson, Richard W McCarthy, et al.
The Journal of Biological Chemistry|January 2, 2015
Tricyclic covalent inhibitors selectively target Jak3 through an active site thiolEric R Goedken, Maria A Argiriadi, David L Banach, et al.
Journal of Medicinal Chemistry|October 29, 2015
Discovery of A-971432, An Orally Bioavailable Selective Sphingosine-1-Phosphate Receptor 5 (S1P5) Agonist for the Potential Treatment of Neurodegenerative DisordersAdrian D Hobson, Christopher M Harris, Elizabeth L van der Kam, et al.
Journal of Medicinal Chemistry|February 12, 2008
3-amino-benzo[d]isoxazoles as novel multitargeted inhibitors of receptor tyrosine kinasesZhiqin Ji, Asma A Ahmed, Daniel H Albert, et al.
Bioorganic & Medicinal Chemistry Letters|November 21, 2009
2,4-Diaminopyrimidine MK2 inhibitors. Part II: Structure-based inhibitor optimizationChristopher M Harris, Anna M Ericsson, Maria A Argiriadi, et al.
Bioorganic & Medicinal Chemistry Letters|November 19, 2009
2,4-Diaminopyrimidine MK2 inhibitors. Part I: Observation of an unexpected inhibitor binding modeMaria A Argiriadi, Anna M Ericsson, Christopher M Harris, et al.
Journal of Medicinal Chemistry|March 9, 2007
Discovery of N-(4-(3-amino-1H-indazol-4-yl)phenyl)-N'-(2-fluoro-5-methylphenyl)urea (ABT-869), a 3-aminoindazole-based orally active multitargeted receptor tyrosine kinase inhibitorYujia Dai, Kresna Hartandi, Zhiqin Ji, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Bioorganic & Medicinal Chemistry Letters|March 30, 2016
Hit-to-lead evaluation of a novel class of sphingosine 1-phosphate lyase inhibitorsJurgen Dinges, Christopher M Harris, Grier A Wallace, et al.
Oecologia|October 17, 2021
Drought at a coastal wetland affects refuelling and migration strategies of shorebirdsAlexandra M Anderson, Christian Friis, Cheri L Gratto-Trevor, et al.
Primer (Leawood, Kan.)|October 4, 2023
Future Doctors From Underrepresented in Medicine Communities at the University of UtahPaloma F Cariello, Edgar Figueroa, Christopher M Harris, et al.
Toxicologic Pathology|June 22, 2016
Syk Inhibition Induces Platelet Dependent Peri-islet Hemorrhage in the Rat PancreasAndrew J Long, Erik Sampson, Richard W McCarthy, et al.
The Journal of Biological Chemistry|January 2, 2015
Tricyclic covalent inhibitors selectively target Jak3 through an active site thiolEric R Goedken, Maria A Argiriadi, David L Banach, et al.
Journal of Medicinal Chemistry|October 29, 2015
Discovery of A-971432, An Orally Bioavailable Selective Sphingosine-1-Phosphate Receptor 5 (S1P5) Agonist for the Potential Treatment of Neurodegenerative DisordersAdrian D Hobson, Christopher M Harris, Elizabeth L van der Kam, et al.
Journal of Medicinal Chemistry|February 12, 2008
3-amino-benzo[d]isoxazoles as novel multitargeted inhibitors of receptor tyrosine kinasesZhiqin Ji, Asma A Ahmed, Daniel H Albert, et al.
Bioorganic & Medicinal Chemistry Letters|November 21, 2009
2,4-Diaminopyrimidine MK2 inhibitors. Part II: Structure-based inhibitor optimizationChristopher M Harris, Anna M Ericsson, Maria A Argiriadi, et al.
Bioorganic & Medicinal Chemistry Letters|November 19, 2009
2,4-Diaminopyrimidine MK2 inhibitors. Part I: Observation of an unexpected inhibitor binding modeMaria A Argiriadi, Anna M Ericsson, Christopher M Harris, et al.
Journal of Medicinal Chemistry|March 9, 2007
Discovery of N-(4-(3-amino-1H-indazol-4-yl)phenyl)-N'-(2-fluoro-5-methylphenyl)urea (ABT-869), a 3-aminoindazole-based orally active multitargeted receptor tyrosine kinase inhibitorYujia Dai, Kresna Hartandi, Zhiqin Ji, et al.
Pageof 7